CIBC Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,025
Closed -$70K 1138
2022
Q3
$70K Hold
15,025
﹤0.01% 1200
2022
Q2
$89K Sell
15,025
-1,099
-7% -$12.2K ﹤0.01% 1206
2022
Q1
$312K Hold
16,124
﹤0.01% 1038
2021
Q4
$527K Buy
16,124
+376
+2% +$15.1K ﹤0.01% 824
2021
Q3
$646K Buy
15,748
+1,369
+10% +$49.7K ﹤0.01% 766
2021
Q2
$518K Hold
14,379
﹤0.01% 802
2021
Q1
$561K Buy
+14,379
New +$647K ﹤0.01% 774

Other funds holding GDRX

CIBC Asset Management's GDRX Position: Q4 2022 in Review

CIBC Asset Management sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 15,025 shares — an estimated $70K sold.

CIBC Asset Management first reported a position in GDRX in Q1 2021 and held it in 7 quarters. The position peaked at $646K in Q3 2021. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

  • CIBC Asset Management reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
  • CIBC Asset Management sold 15,025 GoodRx Holdings shares in Q4 2022, an estimated $70K.
  • CIBC Asset Management first reported a position in GoodRx Holdings in Q1 2021 and held it in 7 quarters.
  • CIBC Asset Management's GoodRx Holdings position peaked at $646K in Q3 2021.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on CIBC Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.